HIV prevention drug PrEP is set to be listed on the Pharmaceutical Benefits Scheme

Ashleigh McMillan
Updated February 8 2018 - 11:01pm, first published 6:00pm
Alfred Hospital’s PrEPX project leader associate professor Edwina Wright said putting the HIV drug PrEP on the Pharmaceutical Benefits Scheme could be "remarkable".
Alfred Hospital’s PrEPX project leader associate professor Edwina Wright said putting the HIV drug PrEP on the Pharmaceutical Benefits Scheme could be "remarkable".

With the possibility that a revolutionary HIV drug will be listed for federal subsidy this week, the head of a study into its effectiveness with trials in Ballarat has touted its importance. 

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options

Get the latest Ballarat news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.